Hearing Preservation and Nanotechnology-based Targeted Drug Delivery Future in Cochlear Implantation?

H. Rask-Andersen, Wei Liu, M. Boström, F. Linthicum
{"title":"Hearing Preservation and Nanotechnology-based Targeted Drug Delivery Future in Cochlear Implantation?","authors":"H. Rask-Andersen, Wei Liu, M. Boström, F. Linthicum","doi":"10.11289/OTOLJPN.19.687","DOIUrl":null,"url":null,"abstract":"Cochlear Implantation (CI) remains as one of the greatest medical achievements in modern medicine. New and innovative strategies continue to be developed to optimize and improve the functional results of CI surgery. Preservation of residual hearing through a-traumatic surgical techniques and electrode arrays may alter indications. Conditions with profound SNHL with preserved low tone hearing may have several causes and pathology may vary accordingly. In patients with progressive adult-onset SNHL neurons may be conserved even after long duration of deafness. IHCs and OHCs, supporting cells, ganglion cells and dendrites may be preserved in the apical region while in the lower turn despite atrophic organ of Corti and loss of lamina fibers ganglion cells can be present even after 28 years duration of deafness. These spiral ganglion cells may be excellent targets for electric stimulation using EAS technique that combines electric and acoustic stimulation in the same ear and utilizes both low frequency acoustic hearing and electric stimulation of preserved neurons. At the moment we are trying to elucidate the mechanism responsible for this preservation in humans and to use this knowledge for future therapy. Nano-technology may offer new possibilities for focused release of drugs and possibly genes to the inner ear. European project“NanoEar”is a concerted action to develop 3rd generation of nanoparticles (NP) for treatment of inner ear deafness. One goal is to target drugs and genes to specific inner ear cells through so-called multifunctional NP which are degradable, non-toxic, traceable and can be released in a controlled and biocompatible way. The small size of the NP may give new properties for technical advancement but risks must also be thoroughly evaluated. Uppsala is a Swedish partner to evaluate NP uptake in vitro in both human and animal spiral ganglion neurons. In my presentation I will show the system of culture spiral ganglion cells and demonstrate their locomotive behaviour and NP intracellular uptake using time lapse video recording and combined immunofluorescence and confocal microscopy.","PeriodicalId":19601,"journal":{"name":"Otology Japan","volume":"42 1","pages":"687-697"},"PeriodicalIF":0.0000,"publicationDate":"2009-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otology Japan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11289/OTOLJPN.19.687","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cochlear Implantation (CI) remains as one of the greatest medical achievements in modern medicine. New and innovative strategies continue to be developed to optimize and improve the functional results of CI surgery. Preservation of residual hearing through a-traumatic surgical techniques and electrode arrays may alter indications. Conditions with profound SNHL with preserved low tone hearing may have several causes and pathology may vary accordingly. In patients with progressive adult-onset SNHL neurons may be conserved even after long duration of deafness. IHCs and OHCs, supporting cells, ganglion cells and dendrites may be preserved in the apical region while in the lower turn despite atrophic organ of Corti and loss of lamina fibers ganglion cells can be present even after 28 years duration of deafness. These spiral ganglion cells may be excellent targets for electric stimulation using EAS technique that combines electric and acoustic stimulation in the same ear and utilizes both low frequency acoustic hearing and electric stimulation of preserved neurons. At the moment we are trying to elucidate the mechanism responsible for this preservation in humans and to use this knowledge for future therapy. Nano-technology may offer new possibilities for focused release of drugs and possibly genes to the inner ear. European project“NanoEar”is a concerted action to develop 3rd generation of nanoparticles (NP) for treatment of inner ear deafness. One goal is to target drugs and genes to specific inner ear cells through so-called multifunctional NP which are degradable, non-toxic, traceable and can be released in a controlled and biocompatible way. The small size of the NP may give new properties for technical advancement but risks must also be thoroughly evaluated. Uppsala is a Swedish partner to evaluate NP uptake in vitro in both human and animal spiral ganglion neurons. In my presentation I will show the system of culture spiral ganglion cells and demonstrate their locomotive behaviour and NP intracellular uptake using time lapse video recording and combined immunofluorescence and confocal microscopy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
听力保护和纳米技术在人工耳蜗植入中的靶向给药前景?
人工耳蜗植入术仍然是现代医学最伟大的医学成就之一。新的和创新的策略不断发展,以优化和改善CI手术的功能结果。通过创伤性手术技术和电极阵列保存残余听力可能会改变适应症。重度SNHL伴有保留的低音调听力可能有多种原因,病理也可能相应不同。在进行性成人SNHL患者中,即使在长时间耳聋后,神经元也可能被保存。耳尖区可保留ihc和OHCs、支持细胞、神经节细胞和树突,而耳尖区,尽管Corti器官萎缩和层纤维丢失,神经节细胞仍可存在,即使耳聋持续28年。这些螺旋神经节细胞可能是使用EAS技术进行电刺激的极好目标,该技术在同一耳中结合电和声刺激,并利用低频声学听力和保存神经元的电刺激。目前,我们正试图阐明在人类中负责这种保存的机制,并将这些知识用于未来的治疗。纳米技术可能为集中释放药物和基因到内耳提供新的可能性。欧洲“纳米耳”项目是一项协同行动,旨在开发用于治疗内耳耳聋的第三代纳米颗粒(NP)。一个目标是通过所谓的多功能NP将药物和基因靶向到特定的内耳细胞,这些NP是可降解的,无毒的,可追溯的,并且可以以可控和生物相容的方式释放。NP的小尺寸可能会为技术进步提供新的特性,但也必须彻底评估风险。Uppsala是瑞典的合作伙伴,在体外评估人类和动物螺旋神经节神经元的NP摄取。在我的演讲中,我将展示培养螺旋神经节细胞的系统,并使用延时视频记录和免疫荧光和共聚焦显微镜联合演示它们的运动行为和NP细胞内摄取。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
人工聴覚器手術のTips & developments ~術後合併症予防を目指したBaha手術法と骨導インプラントの今後~ 当科で経験したANCA関連血管炎性中耳炎(OMAAV)症例の臨床的検討 蝸牛全解析のための透明化技術開発(Modified Sca/eS) 上鼓室・乳突腔病巣処理を伴う鼓室形成術の術式名称について(2020) 聴神経腫瘍診療における「早期発見,早期治療」
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1